Topic analysis

Thousands more UK black men to be invited for prostate cancer screening

UK Health Secretary James Murray accepted recommendations from the UK National Screening Committee (UKNSC) to screen only a few thousand high-risk men with BRCA2 genetic mutations for prostate cancer every two years (ages 45-61), rejecting population-wide or broader at-risk group screening over concerns the PSA test may cause more harm than good. He also announced £20m in funding for prostate cancer research and treatment, including expanding the Transform trial to invite more UK black men aged 45-74 (without recent PSA tests or MRIs) to participate, though the decision has drawn criticism from campaigners who argue it perpetuates health inequalities.